The gastrointestinal effects of metoclopramide does not include:
**Core Concept**
Metoclopramide is a prokinetic agent that primarily works by enhancing gastrointestinal motility. It acts on the gastrointestinal tract by stimulating dopamine D2 receptors, which are involved in the regulation of gut motility. This action results in increased contractions of the upper gastrointestinal tract, including the stomach and small intestine.
**Why the Correct Answer is Right**
Metoclopramide's mechanism of action involves the blockade of dopamine D2 receptors in the gastrointestinal tract, leading to increased acetylcholine release and subsequent contraction of smooth muscle cells. This results in accelerated gastric emptying and increased motility of the small intestine. Additionally, metoclopramide has a prokinetic effect on the upper gastrointestinal tract, which helps to alleviate symptoms of gastroparesis and other conditions characterized by delayed gastric emptying.
**Why Each Wrong Option is Incorrect**
**Option A:** Not applicable as this option is missing.
**Option B:** This option is incorrect as metoclopramide does indeed cause gastrointestinal effects, including increased motility and gastric emptying.
**Option C:** This option is incorrect as metoclopramide can cause gastrointestinal side effects such as nausea, vomiting, and diarrhea, but it does not have a direct effect on the large intestine.
**Clinical Pearl / High-Yield Fact**
Metoclopramide is a useful agent in the treatment of gastroparesis and other conditions characterized by delayed gastric emptying. However, its use is limited by the risk of extrapyramidal side effects, such as dystonia and parkinsonism, which are more common in older adults and patients with a history of psychiatric illness.
**Correct Answer:** D.